Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
71
PharmaCompass offers a list of Lifitegrast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lifitegrast manufacturer or Lifitegrast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lifitegrast manufacturer or Lifitegrast supplier.
PharmaCompass also assists you with knowing the Lifitegrast API Price utilized in the formulation of products. Lifitegrast API Price is not always fixed or binding as the Lifitegrast Price is obtained through a variety of data sources. The Lifitegrast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 038E5L962W manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 038E5L962W, including repackagers and relabelers. The FDA regulates 038E5L962W manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 038E5L962W API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 038E5L962W manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 038E5L962W supplier is an individual or a company that provides 038E5L962W active pharmaceutical ingredient (API) or 038E5L962W finished formulations upon request. The 038E5L962W suppliers may include 038E5L962W API manufacturers, exporters, distributors and traders.
click here to find a list of 038E5L962W suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 038E5L962W DMF (Drug Master File) is a document detailing the whole manufacturing process of 038E5L962W active pharmaceutical ingredient (API) in detail. Different forms of 038E5L962W DMFs exist exist since differing nations have different regulations, such as 038E5L962W USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 038E5L962W DMF submitted to regulatory agencies in the US is known as a USDMF. 038E5L962W USDMF includes data on 038E5L962W's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 038E5L962W USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 038E5L962W suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 038E5L962W Drug Master File in Korea (038E5L962W KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 038E5L962W. The MFDS reviews the 038E5L962W KDMF as part of the drug registration process and uses the information provided in the 038E5L962W KDMF to evaluate the safety and efficacy of the drug.
After submitting a 038E5L962W KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 038E5L962W API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 038E5L962W suppliers with KDMF on PharmaCompass.
A 038E5L962W written confirmation (038E5L962W WC) is an official document issued by a regulatory agency to a 038E5L962W manufacturer, verifying that the manufacturing facility of a 038E5L962W active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 038E5L962W APIs or 038E5L962W finished pharmaceutical products to another nation, regulatory agencies frequently require a 038E5L962W WC (written confirmation) as part of the regulatory process.
click here to find a list of 038E5L962W suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 038E5L962W as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 038E5L962W API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 038E5L962W as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 038E5L962W and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 038E5L962W NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 038E5L962W suppliers with NDC on PharmaCompass.
038E5L962W Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 038E5L962W GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 038E5L962W GMP manufacturer or 038E5L962W GMP API supplier for your needs.
A 038E5L962W CoA (Certificate of Analysis) is a formal document that attests to 038E5L962W's compliance with 038E5L962W specifications and serves as a tool for batch-level quality control.
038E5L962W CoA mostly includes findings from lab analyses of a specific batch. For each 038E5L962W CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
038E5L962W may be tested according to a variety of international standards, such as European Pharmacopoeia (038E5L962W EP), 038E5L962W JP (Japanese Pharmacopeia) and the US Pharmacopoeia (038E5L962W USP).
